Marillion Pharmaceuticals' Series A Round

Marillion Pharmaceuticals raised a round of funding on February 04, 2006. Investors include APIDC Venture Capital.

Marillion Pharmaceuticals, Inc. - Marillion is developing clinical-stage drugs in oncology and oncology supportive care. 177Lu-AMBA is a targeted radiotherapeutic, with the low level radiation of lu…

Articles about Marillion Pharmaceuticals' Series A Round: